PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Varenicline Tartrate Tablets | 0.5mg |
 |
53 |
70748-127-49 |
Chantix® |
AB |
Smoking Cessation Aids |
| Turqoz™ | 0.3mg/0.03mg |
 |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
| Thiamine Hydrochloride Injection USP | 200mg/2ml (100mg/ml) |
|
25ml |
70748-347-02 |
Thiamine Hydrochloride Injection USP |
AP |
B1 Vitamins |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate for oral solution. | 1.6g per 6 ounces |
 |
177mL |
43386-700-83 |
Suprep® Bowel Prep Kit |
AA |
Osmotic Laxative |
| Sildenafil for Oral Suspension | 10mg/mL |
 |
112mL |
68180-283-01 |
Revatio® |
AB |
Phosphodiesterase-5 (PDE-5) Inhibitors |
| Sevelamer Hydrochloride Tablets | 800mg |
|
180 |
70748-173-26 |
Renagel® |
AB |
Phosphate binders |
| Rufinamide Tablets USP | 200mg |
|
120 |
68180-803-16 |
Banzel® |
AB |
Anticonvulsants |
| Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
|
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
| Paliperidone Extended-Release Tablet | 1.5mg |
|
30 |
68180-523-06 |
Invega® |
AB |
Atypical antipsychotics |
| Nitrofurantoin Macrocrystalline Capsules USP | 50mg |
|
100 |
43386-641-01 |
Macrodantin® |
AB |
Antibiotic |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
|
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
|
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
| Lurasidone Hydrochloride Tablets | 20mg |
|
30 |
68180-674-06 |
Latuda® |
AB |
Atypical antipsychotics |
| Ibuprofen and Famotidine Tablets | 800mg/ 26.6mg |
 |
90 |
70748-312-09 |
Duexis® |
AB |
NSaID |
| Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
| Fenofibrate Capsules | 90mg |
|
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
| Doxycycline Monohydrate Capsules USP | 50mg |
|
50 |
68180-650-01 |
Monodox® |
AB |
Anti-Infectives |
| Diclofenac Sodium Topical Solution | 2% |
|
112g |
68180-537-01 |
Pennsaid® 2% |
AB |
Topical nonsteroidal anti-inflammatory drug (NSAID) |
| Diazepam Rectal Gel | 10 mg & 20 mg |
|
4.4 cm & 6.0 cm |
43386-281-01 |
|||
| Desvenlafaxine Extended-Release Tablets | 25mg |
|
30 |
68180-592-06 |
Pristiq® |
AB |
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) |
| Desoximetasone Topical Spray | 0.25% |
 |
100 mL |
68180-944-33 |
Topicort® Topical Spray |
AT |
Corticosteroid |
| Desoximetasone Ointment USP | 0.05% |
 |
15g |
68180-948-04 |
Topicort® Ointment |
AB |
Corticosteroid |
| Desoximetasone Cream USP | 0.05% |
 |
15g |
68180-950-04 |
Topicort® LP Emollient Cream (0.05%) Topicort® Cream (0.25%) |
AB |
Corticosteroid |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
